Rituximab for refractory ocular symptoms in myasthenia gravis with thyroid eye disease: a case report with quantitative MRI assessment
Dingxian He, Xiangwen Li, Baitong Wang, Yaqi Wang, Chong Yan, Mengxiao Liu, Tom Hibert, Sushan Luo, Chongbo Zhao, Jianying Xi · 2025
Read Rituximab for refractory ocular symptoms in myasthenia gravis with thyroid eye disease: a case report with quantitative MRI assessment by Dingxian He, Xiangwen Li, Baitong Wang, Yaqi Wang, Chong Yan, Mengxiao Liu, Tom Hibert, Sushan Luo, Chongbo Zhao, Jianying Xi (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12695779.txt.
Description
AimsTo report a case with concurrent myasthenia gravis (MG) and thyroid eye disease (TED) showing response to rituximab (RTX) through both clinical evaluation and quantitative MRI assessment.MethodsA 31-year-old female patient with refractory ocular symptoms from concurrent MG and TED received RTX after failing multiple conventional treatments.
Catalog record
| CREATOR | Dingxian He, Xiangwen Li, Baitong Wang, Yaqi Wang, Chong Yan, Mengxiao Liu, Tom Hibert, Sushan Luo, Chongbo Zhao, Jianying Xi |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 21 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |